Takeda Pharmaceuticals America, Inc.: all contributions
2025–2026 · Reported individual contributions grouped by employer.
These are contributions by individuals, not by their employer, industry, or location. Refunds remain negative; memo-only rows are marked and are not additional money.
← Back to Takeda Pharmaceuticals America, Inc.Showing the last prepared contribution list. Updated records are not ready.
| # | Reported contributor / location | Reported employer / occupation | Recipient / reporting committee | Date ↕ | Amount ↑ | Election | Filing details / source |
|---|---|---|---|---|---|---|---|
| 261 | CLIFFORD, ALISONCAMBRIDGEMA02142 | DIRECTOR THERAPEUTIC POLICY AND ADVOCATAKEDA PHARMACEUTICALS AMERICA INC. | TAKEDA PHARMACEUTICALS AMERICA INC. POLITICAL ACTION COMMITTEEC00441733 | 2025-12-31 | $70 | Primary (P) | P/R DEDUCTION ($35.00 BI-WEEKLY)Filing 1934071FEC filing ↗ |
| 262 | PERTILE, SCOTTCAMBRIDGEMA02142 | ONCOLOGY TERRITORY MANAGER HEMETAKEDA PHARMACEUTICALS AMERICA INC. | TAKEDA PHARMACEUTICALS AMERICA INC. POLITICAL ACTION COMMITTEEC00441733 | 2025-12-31 | $70 | Primary (P) | P/R DEDUCTION ($35.00 BI-WEEKLY)Filing 1934071FEC filing ↗ |
| 263 | MORRIS, NATALIE DCAMBRIDGEMA |
One page is fetched at a time, with one extra row to check for the next page. Current amendment versions are selected before pagination. Raw reported names and filing values are preserved. This list covers locally ingested FEC individual-contribution records, not undisclosed or unitemized contributor identities.